IL-13 (Sanofi)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameIL-13 (Sanofi)
Drug Alias Nameinterleukin-13 (Sanofi)IL-13
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionInterleukin 13 receptor agonists
TargetsInterleukin 13 receptor
Therapy Area/IndicationsArthritis, RheumatoidNeoplasmsHIV Infections +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSanofi
Active IndicationsN/A
Inactive IndicationsArthritis, RheumatoidNeoplasmsHIV Infections +[4] 

Other Information

ATC CodeN/A
Related LinksN/A